###begin article-title 0
Influenza B Virus Ribonucleoprotein Is a Potent Activator of the Antiviral Kinase PKR
###end article-title 0
###begin p 1
Current address: Department of Medical Microbiology & Immunology, University of Alberta, Edmonton, Alberta, Canada
###end p 1
###begin p 2
Conceived and designed the experiments: BD AGS TW. Performed the experiments: BD LMS JS RH. Analyzed the data: BD LMS JS RH AGS TW. Contributed reagents/materials/analysis tools: ZW UK. Wrote the paper: BD TW.
###end p 2
###begin p 3
###xml 544 561 <span type="species:ncbi:11520">influenza B virus</span>
###xml 1052 1069 <span type="species:ncbi:11520">influenza B virus</span>
###xml 1420 1424 <span type="species:ncbi:10090">mice</span>
Activation of the latent kinase PKR is a potent innate defense reaction of vertebrate cells towards viral infections, which is triggered by recognition of viral double-stranded (ds) RNA and results in a translational shutdown. A major gap in our understanding of PKR's antiviral properties concerns the nature of the kinase activating molecules expressed by influenza and other viruses with a negative strand RNA genome, as these pathogens produce little or no detectable amounts of dsRNA. Here we systematically investigated PKR activation by influenza B virus and its impact on viral pathogenicity. Biochemical analysis revealed that PKR is activated by viral ribonucleoprotein (vRNP) complexes known to contain single-stranded RNA with a 5'-triphosphate group. Cell biological examination of recombinant viruses showed that the nucleo-cytoplasmic transport of vRNP late in infection is a strong trigger for PKR activation. In addition, our analysis provides a mechanistic explanation for the previously observed suppression of PKR activation by the influenza B virus NS1 protein, which we show here to rely on complex formation between PKR and NS1's dsRNA binding domain. The high significance of this interaction for pathogenicity was revealed by the finding that attenuated influenza viruses expressing dsRNA binding-deficient NS1 proteins were rescued for high replication and virulence in PKR-deficient cells and mice, respectively. Collectively, our study provides new insights into an important antiviral defense mechanism of vertebrates and leads us to suggest a new model of PKR activation by cytosolic vRNP complexes, a model that may also be applicable to other negative strand RNA viruses.
###end p 3
###begin title 4
Author Summary
###end title 4
###begin p 5
###xml 90 93 90 93 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">via</italic>
###xml 893 910 <span type="species:ncbi:11520">influenza B virus</span>
###xml 1122 1126 <span type="species:ncbi:10090">mice</span>
Upon viral infection of vertebrate cells, a vigorous innate defense response is initiated via the recognition of viral double-stranded (ds) RNA by the protein kinase PKR, resulting in the cessation of protein synthesis and subsequent blockage of viral propagation. The activation of PKR's potent antiviral response against influenza and other viruses with a negative strand RNA genome has presented a conundrum, however, as previous attempts failed to detect dsRNA in cells infected with these viruses. Here, we identify genomic RNA within the ribonucleoprotein (RNP) of influenza viruses as a non-canonical activator of the latent kinase PKR. Cell biological examinations revealed that the transfer of viral RNP from the nucleus to the cytoplasm provides a strong stimulus for PKR activation. Moreover, we provide insight into mechanisms of pathogenesis by showing PKR and the NS1 protein of influenza B virus forms a complex in infected cells, which inhibits PKR activation. This interaction seems to be crucial for viral pathogenicity, as a strong attenuation of NS1 mutant viruses was largely rescued in PKR-deficient mice and cells. Taken together, these findings suggest a new model for the induction and inhibition of PKR by influenza virus that may also apply to viruses with a similar genome structure.
###end p 5
###begin title 6
Introduction
###end title 6
###begin p 7
###xml 191 194 191 194 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000473-GarciaSastre1">[1]</xref>
###xml 372 375 372 375 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000473-Sadler1">[2]</xref>
###xml 376 379 376 379 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000473-Garcia1">[3]</xref>
###xml 565 568 565 568 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000473-Meurs1">[4]</xref>
###xml 725 728 725 728 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000473-Kuhen1">[5]</xref>
###xml 947 950 947 950 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000473-Sadler1">[2]</xref>
###xml 1238 1241 1234 1237 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000473-Sadler1">[2]</xref>
###xml 1242 1245 1238 1241 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000473-Garcia1">[3]</xref>
###xml 1429 1432 1421 1424 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000473-Garcia1">[3]</xref>
###xml 381 386 <span type="species:ncbi:9606">Human</span>
The presence and replication of viral nucleic acids in vertebrate cells triggers innate immune responses by the activation of antiviral enzymes and induction of type I interferon (IFN) genes [1]. The double-stranded (ds) RNA-dependent protein kinase PKR is a key mediator of this innate immune defense functioning as a signal transducer in a variety of cellular processes [2],[3]. Human PKR is a latent serine/threonine kinase of 551 amino acids with two consecutive N-terminal double-strand (ds) RNA-binding motifs, a linker domain, and a C-terminal kinase domain [4]. PKR is present in non-stimulated cells at basal levels, but its expression is upregulated by type I IFN, which allows a robust response to viral infection [5]. Activation of PKR during infection involves recognition of viral nucleic acids, which induces a structural rearrangement leading to dimerization and autophosphorylation of the kinase at threonine residues 446 and 451 [2]. The best-studied natural target site of activated PKR is serine 51 of the alpha subunit of the eukaryotic translation initiation factor 2 (eIF2alpha). Its phosphorylation brings about a translational block of cellular and viral mRNAs and hence, a strong impairment of viral replication [2],[3]. In addition, PKR controls transcriptional activation of the nuclear factor-kappa B (NF-kappaB) pathway and was also shown to mediate apoptosis and to function as a tumour suppressor [3].
###end p 7
###begin p 8
###xml 130 133 130 133 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000473-Garcia1">[3]</xref>
###xml 134 137 134 137 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000473-Gale1">[6]</xref>
###xml 440 443 436 439 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000473-Garcia1">[3]</xref>
###xml 550 553 546 549 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000473-Manche1">[7]</xref>
###xml 838 841 834 837 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000473-Jacobs1">[8]</xref>
###xml 1038 1041 1034 1037 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000473-Jacobs1">[8]</xref>
###xml 1274 1277 1270 1273 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000473-Pichlmair1">[9]</xref>
###xml 1278 1282 1274 1278 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000473-Weber1">[10]</xref>
###xml 695 709 <span type="species:ncbi:10245">vaccinia virus</span>
###xml 846 854 <span type="species:ncbi:10891">reovirus</span>
Many virus families have evolved gene products targeting PKR, illustrating the high relevance of this kinase in antiviral defense [3],[6]. The inhibitory mechanisms include PKR degradation, sequestration of viral dsRNA by a viral protein, preventing PKR activation through inhibitory viral proteins or viral decoy RNA, and regulating the phosphorylation of eIF2alpha through a viral pseudosubstrate or recruitment of a cellular phosphatase [3]. Early studies identified dsRNA with a minimum length of 34 base pairs as a prototypical activator of PKR [7] and the sources of these kinase-inducing nucleic acids have been well recognized for several classes of viruses: Complex DNA viruses such as vaccinia virus, adenovirus or herpes simplex virus transcribe open reading frames in opposite orientations leading to formation of duplex RNAs [8]. In reovirus-infected cells, the viral genome consists of dsRNA and also the genomes of many plus-strand RNA viruses contain long stretches of extensively base-paired secondary structure elements [8]. Surprisingly, there is little knowledge about the specific nucleic acids of influenza and other negative-sense RNA viruses that trigger PKR activation, as earlier attempts failed to detect dsRNA in cells infected with such viruses [9],[10]. Progress in this area has been hampered in part by viral suppressors of PKR, which necessitates the application of reverse genetic procedures for such analyses.
###end p 8
###begin p 9
###xml 72 88 72 88 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Orthomyxoviridae</italic>
###xml 383 387 383 387 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000473-Palese1">[11]</xref>
###xml 748 751 748 751 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">via</italic>
###xml 833 837 833 837 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000473-Palese1">[11]</xref>
###xml 944 947 944 947 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000473-Jacobs1">[8]</xref>
###xml 948 952 948 952 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000473-Majde1">[12]</xref>
###xml 1064 1068 1064 1068 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000473-Palese1">[11]</xref>
###xml 1120 1124 1120 1124 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000473-Tian1">[13]</xref>
###xml 1236 1240 1236 1240 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000473-Li1">[14]</xref>
The influenza A and B viruses are globally distributed pathogens of the Orthomyxoviridae family that cause acute severe respiratory disease and around 40,000 deaths each year in the European Union alone (). These viruses have a segmented genome that consists of eight single-stranded viral RNAs (vRNA) of negative polarity with short complementary sequences at their 5'- and 3'-ends [11]. The vRNAs carry a triphosphate group at their 5'-ends and associate with the viral polymerase complex and the nucleoprotein NP into viral ribonucleoprotein (vRNP). In the nucleus, the viral polymerase synthesizes mRNAs and positive strand cRNAs that serve as templates for new vRNAs. Progeny vRNPs are exported to the cytoplasm in the late phase of infection via the CRM1-pathway to facilitate virus assembly and budding at the plasma membrane [11]. It has been suggested that hypothetical dsRNA intermediates produced during virus replication induce PKR [8],[12]. Such a scenario is unlikely, however, as production of viral RNAs with opposite polarities is a nuclear event [11], whereas activation of PKR occurs in the cytoplasm [13]. It was also proposed that influenza virus infection induces PACT, a stress-activated protein activator of PKR [14], but the dependency of PKR induction on PACT expression during viral infection has not been reported yet.
###end p 9
###begin p 10
###xml 290 294 290 294 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000473-Bergmann1">[15]</xref>
###xml 295 299 295 299 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000473-Hatada1">[17]</xref>
###xml 603 607 603 607 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000473-Yin1">[18]</xref>
###xml 649 657 649 657 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 709 713 709 713 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000473-Wang1">[19]</xref>
###xml 1318 1322 1318 1322 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000473-Dauber1">[16]</xref>
###xml 1324 1328 1324 1328 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000473-Dauber2">[20]</xref>
###xml 1329 1333 1329 1333 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000473-Wang2">[26]</xref>
###xml 1569 1573 1569 1573 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000473-delaLuna1">[27]</xref>
###xml 1574 1578 1574 1578 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000473-Satterly1">[35]</xref>
###xml 1739 1743 1739 1743 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000473-Lenschow1">[36]</xref>
###xml 1744 1748 1744 1748 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000473-Yuan1">[37]</xref>
###xml 1834 1838 1834 1838 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000473-Schneider1">[38]</xref>
###xml 107 114 <span type="species:ncbi:10325">B virus</span>
###xml 1626 1643 <span type="species:ncbi:11520">influenza B virus</span>
Despite uncertainty regarding the mode of PKR stimulation, it is well established that the influenza A and B virus NS1 proteins (A/NS1 and B/NS1, respectively) function as PKR antagonists since mutant viruses with defects in the NS1 gene, but not wild-type virus, are potent PKR activators [15]-[17]. The NS1 proteins of both virus types are multifunctional proteins consisting of 202-237 and 281 amino acids (aa), respectively. Although their overall sequence identity is below 25%, they carry a similarly structured N-terminal dsRNA binding domain located at positions 1-73 (type A) and 1-93 (type B) [18]. Both NS1 proteins bind to the same RNAs in vitro including synthetic dsRNA, U6 RNA, and poly(A)-RNA [19]; however, at present it is unclear whether the NS1 proteins sequester viral dsRNA in the same way as other viral PKR antagonistic proteins, how dsRNA binding is related to PKR inhibition and if the A/NS1 and B/NS1 proteins block PKR activation by the same or different mechanism(s). Interpretation of studies aiming to define the interactions of influenza viruses with PKR and their significance for virus propagation is complex due to the multifaceted nature of NS1 protein function. The NS1 proteins not only inhibit PKR, but also downregulate the signals leading to the activation of type I IFN genes [16], [20]-[26]. Moreover, the A/NS1 protein was shown to inhibit the maturation and export of cellular pre-mRNAs, to enhance translation, to inhibit the 2'-5'- oligo adenylate synthetase (OAS) and to activate the phosphatidylinositol 3-kinase (PI3K) [27]-[35]. In contrast, it is a specific function of the influenza B virus NS1 protein to inhibit the conjugation of the antiviral ISG15 gene product to cellular targets [36],[37]. The B/NS1 protein was recently also shown to modify the nuclear speckle compartment [38]. Thus, a given mutation in the NS1 gene may affect multiple functions, thereby complicating the assignment of a specific host factor as being responsible for a certain phenotype.
###end p 10
###begin p 11
###xml 342 350 342 350 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 637 645 637 645 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 650 657 650 657 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 502 519 <span type="species:ncbi:11520">influenza B virus</span>
In the present report, we propose a novel concept for the induction and control of PKR by influenza viruses that may also apply to other negative strand RNA viruses. Analysis of recombinant viruses showed that activation of PKR is triggered upon the appearance of viral RNP in the cytoplasm late in infection. This reaction was recapitulated in vitro by finding that purified viral RNP complexes induce PKR autophosphorylation. Genetic complementation analysis demonstrated that the blockade of PKR by influenza B virus is facilitated by the NS1 protein's dsRNA binding activity, which was also essential for efficient viral replication in vitro and in vivo. Finally, the antagonistic activity of the NS1 protein was explained by its capacity to form a physical complex with PKR.
###end p 11
###begin title 12
Results
###end title 12
###begin title 13
PKR deficiency rescues attenuated replication and virulence of influenza B mutant viruses with dsRNA-binding deficient NS1 proteins
###end title 13
###begin p 14
###xml 261 265 257 261 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000473-Dauber1">[16]</xref>
###xml 266 270 262 266 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000473-Donelan1">[21]</xref>
###xml 272 279 268 275 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000473-g001">Fig. 1A</xref>
###xml 289 305 285 301 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">loss-of-function</italic>
###xml 559 563 555 559 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000473-Dauber1">[16]</xref>
###xml 773 777 769 773 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000473-Dauber1">[16]</xref>
###xml 134 151 <span type="species:ncbi:11520">influenza B virus</span>
Our previous analyses revealed three basic amino acid clusters at positions 47/50, 58/60/64 and 77/78 in the N-terminal region of the influenza B virus NS1 protein to be essential for dsRNA binding as well as for inhibition of PKR and eIF2alpha phosphorylation [16],[21] (Fig. 1A). Hence, loss-of-function viruses expressing NS1 proteins with alanine replacements at those essential positions (mutants #2, #4, #6) or at amino acids 33/38 (mutant #1, dsRNA binding reduced) were attenuated for replication in IFN-competent hosts by several orders of magnitude [16]. In contrast, viruses expressing NS1 proteins with alanine replacements at positions 52/53/54 or 83/86 (mutants #3 and #7), which retained dsRNA binding, inhibited PKR activation and replicated to high titers [16].
###end p 14
###begin title 15
###xml 34 51 <span type="species:ncbi:11520">influenza B virus</span>
The dsRNA binding activity of the influenza B virus NS1 protein is dispensable for efficient viral replication and pathogenicity in PKR-deficient hosts.
###end title 15
###begin p 16
###xml 258 262 258 262 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000473-Donelan1">[21]</xref>
###xml 519 523 515 519 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000473-Dauber1">[16]</xref>
###xml 532 535 528 531 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 542 545 538 541 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1040 1043 1036 1039 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1123 1124 1119 1120 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sup>
###xml 871 875 <span type="species:ncbi:10090">mice</span>
###xml 1065 1069 <span type="species:ncbi:10090">mice</span>
###xml 1170 1179 <span type="species:ncbi:11601">Lee virus</span>
###xml 1214 1218 <span type="species:ncbi:10090">mice</span>
(A) The schematic diagram shows basic amino acid residues in the dsRNA-binding domain of the NS1 protein. NS1 proteins with alanine exchange mutations at the indicated positions have been shown to have strong (+), weak (+/-) or no (-) dsRNA binding activity [21]. Recombinant influenza B viruses expressing NS1 proteins with abolished dsRNA-binding and mutant virus #1 did not inhibit PKR activation and eIF2alpha phosphorylation (-), whereas viruses expressing dsRNA binding NS1 proteins inhibited PKR as WT virus (+) [16]. (B) PKR+/+ or PKR-/- MEFs were infected with WT virus, delNS1 virus or NS1 mutant viruses #1, #2, #3, #4, #6 or #7 at an MOI of 0.1. Virus titers were determined at the indicated time points and represent the average of two independent experiments performed as duplicates. Error bars indicate the standard deviation. (C) For infection studies in mice the indicated representative recombinant influenza B/Lee viruses were chosen according to their ability to block PKR activation. Groups of eight-week-old female PKR-/- and wild type C57BL6 mice were anesthetized and infected intranasally with 1x105 ffu of the indicated recombinant influenza B/Lee virus. For viral lung titrations, three mice were sacrificed at day 3 and at day 6 post-infection and virus titers were determined in lung homogenates. Error bars indicate the standard deviation. Statistical analysis indicated significant differences between WT and mutant virus titers. *, p<0.05; **, p<0.01; n.d., not detectable. Other recombinant viruses were not tested in this setting.
###end p 16
###begin p 17
###xml 233 236 233 236 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 230 236 230 236 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PKR<sup>+/+</sup></italic>
###xml 244 247 244 247 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 241 247 241 247 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PKR<sup>&#8722;/&#8722;</sup></italic>
###xml 254 261 254 261 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000473-g001">Fig. 1B</xref>
###xml 329 332 329 332 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 326 332 326 332 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PKR<sup>+/+</sup></italic>
###xml 340 343 340 343 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 337 343 337 343 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PKR<sup>&#8722;/&#8722;</sup></italic>
###xml 375 376 375 376 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sup>
###xml 702 703 702 703 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sup>
###xml 798 799 798 799 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sup>
###xml 943 944 943 944 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sup>
###xml 955 956 955 956 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sup>
###xml 248 252 <span type="species:ncbi:10090">mice</span>
###xml 622 627 <span type="species:ncbi:10090">mouse</span>
To address the question of whether PKR or another antiviral factor was mainly responsible for the attenuation of viruses with dsRNA binding-defective NS1 protein, we conducted a growth curve analysis in embryonic fibroblasts from PKR+/+ and PKR-/- mice (Fig. 1B). The WT and control mutant virus #3 replicated equally well in PKR+/+ and PKR-/- cells reaching titers of 1-2x106 FFU/ml. Replication of mutant virus #7 was slightly lower, but this characteristic was independent of the PKR status. In contrast, replication of mutant viruses #2, #4 and #6 expressing dsRNA-binding defective NS1 proteins was reduced in normal mouse embryonic fibroblasts (MEF) by about three orders of magnitude (1.5-7.1x103 FFU/ml) in comparison to WT. The mutant virus #1 replicated to a slightly higher titer (4.9x104 FFU/ml). Significantly, the absence of PKR strongly boosted replication of all four mutant viruses (#1, #2, #4 and #6) to titers between 5.4x105 and 1.1x106 FFU/ml. Interestingly, minimal replication of the isogenic virus with a complete deletion of the NS1 gene (delNS1 virus) was observed both in the absence and presence of PKR, pointing to a vital NS1 function beyond the inhibition of PKR.
###end p 17
###begin p 18
###xml 39 46 39 46 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 138 141 138 141 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 135 141 135 141 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PKR<sup>&#8722;/&#8722;</sup></italic>
###xml 147 151 147 151 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000473-Yang1">[39]</xref>
###xml 207 208 207 208 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sup>
###xml 214 221 214 221 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000473-g001">Fig. 1C</xref>
###xml 590 593 590 593 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 587 593 587 593 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PKR<sup>&#8722;/&#8722;</sup></italic>
###xml 759 762 759 762 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 756 762 756 762 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PKR<sup>&#8722;/&#8722;</sup></italic>
###xml 886 889 886 889 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1023 1027 1023 1027 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000473-Hai1">[40]</xref>
###xml 1068 1076 1068 1076 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 1081 1088 1081 1088 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 1429 1437 1429 1437 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="ppat.1000473.s001">Fig. S1A</xref>
###xml 1644 1647 1644 1647 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1641 1647 1641 1647 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PKR<sup>&#8722;/&#8722;</sup></italic>
###xml 1880 1888 1880 1888 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="ppat.1000473.s001">Fig. S1B</xref>
###xml 142 146 <span type="species:ncbi:10090">mice</span>
###xml 341 345 <span type="species:ncbi:10090">mice</span>
###xml 594 598 <span type="species:ncbi:10090">mice</span>
###xml 681 685 <span type="species:ncbi:10090">mice</span>
###xml 890 894 <span type="species:ncbi:10090">mice</span>
###xml 1136 1142 <span type="species:ncbi:10090">murine</span>
###xml 1309 1313 <span type="species:ncbi:10090">mice</span>
###xml 1571 1575 <span type="species:ncbi:10090">mice</span>
###xml 1648 1652 <span type="species:ncbi:10090">mice</span>
###xml 1851 1855 <span type="species:ncbi:10090">mice</span>
###xml 1963 1980 <span type="species:ncbi:11520">influenza B virus</span>
To evaluate NS1 dsRNA binding activity in vivo, we compared the growth of WT and selected mutant viruses in the lungs of wild-type and PKR-/- mice [39] three and six days after intranasal infection with 1x105 FFU (Fig. 1C). This dose was the highest applicable amount possible, due to the low growth of some of the mutant viruses. Wild-type mice had strongly reduced lung titers (by about two orders of magnitude) of the mutants expressing dsRNA-binding deficient NS1 proteins (#2 and #4), in comparison to WT virus and control mutant #7; even so, all three mutant viruses replicated in PKR-/- mice to a similar extent as the WT. The delNS1 virus was not detected at all in normal mice. However, visible delNS1 virus titers were determined in the lungs of PKR-/- animals, which were, however, considerably reduced compared to WT virus. A similar strong attenuation of replication in PKR-/- mice was recently reported for an influenza B/Yamagata/88 mutant virus expressing a severely truncated NS1 protein of 18 amino acids [40]. The differences in delNS1 virus growth in vitro and in vivo might be due to a higher permissiveness of the murine respiratory tract in the absence of PKR compared to fibroblasts, or the slightly different genetic backgrounds of the PKR-deficient animals and cells studied. All WT mice survived the challenge with each virus, but there were marked differences in the body weights of infected animals (Fig. S1A). WT and the control mutant virus #7 caused a transient weight loss of up to 15%, whereas there was little or no weight reduction in mice infected with the mutants #2, #4 or delNS1 virus. Interestingly, PKR-/- mice rapidly lost weight and succumbed to infection between day 7 and 9 after challenge with the WT and all four viruses expressing mutant NS1 proteins, but there was little weight loss in PKR-deficient mice after delNS1 infection (Fig. S1B). These findings demonstrate that PKR can strongly inhibit replication of influenza B virus; however, PKR can be impeded by the dsRNA binding function of the viral NS1 protein.
###end p 18
###begin title 19
DsRNA-binding NS1 proteins form an RNase-sensitive complex with PKR in infected cells
###end title 19
###begin p 20
###xml 180 187 180 187 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000473-g002">Fig. 2A</xref>
###xml 536 540 536 540 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000473-Dauber1">[16]</xref>
###xml 541 545 541 545 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000473-Donelan1">[21]</xref>
###xml 707 714 707 714 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000473-g002">Fig. 2B</xref>
###xml 142 147 <span type="species:ncbi:9606">human</span>
To test the hypothesis that NS1 forms a complex with PKR involving dsRNA, we first immunoprecipitated lysates of WT and mutant virus-infected human A549 cells with anti-NS1 serum (Fig. 2A). Immunoblot analysis showed that PKR was specifically coprecipitated with dsRNA binding NS1 proteins expressed by the WT and mutant viruses #1, #3 and #7. In contrast, very little or no PKR was detected in precipitates containing the dsRNA binding-deficient NS1 proteins of the mutant viruses #2, #4 and #6, that fail to prevent activation of PKR [16],[21]. Further analysis showed that pre-treatment of lysate with dsRNA-specific RNase III eliminated the detection of WT NS1-PKR complexes in a dose-dependent manner (Fig. 2B). These results suggest that dsRNA-binding of the NS1 protein is a prerequisite for complex formation with PKR.
###end p 20
###begin title 21
The dsRNA-binding activity of the NS1 protein mediates interaction with PKR.
###end title 21
###begin p 22
###xml 4 9 <span type="species:ncbi:9606">Human</span>
(A) Human A549 lung epithelial cells were mock treated or infected with WT virus or the NS1 mutant viruses #1, #2, #3, #4, #6 or #7 at an MOI of 1. Lysates were subjected to immunoprecipitation (IP) with NS1 antiserum (alpha) or pre-serum (ctrl). The precipitated complexes were analyzed by immunoblotting with antibodies specific for PKR (upper panel) and NS1 (lower panel). Whole cell lysates were also analyzed with antibodies specific for PKR, tubulin and NS1 as indicated. (B) A549 cells were mock treated or infected with WT virus at an MOI of 1. Lysates were prepared that were either mock treated (-) or treated with the indicated amounts of RNase III for 10 minutes at 33degreesC prior to immunoprecipitation with NS1 antiserum (alpha) or pre-serum (ctrl). The precipitates were analyzed as described in panel 2A (panel to the left). Aliquots of the lysates were also analyzed directly by immunoblotting for PKR, tubulin and NS1 as indicated (panels to the right).
###end p 22
###begin title 23
Wild-type but not dsRNA binding-deficient NS1 protein co-sediments with PKR and viral RNP
###end title 23
###begin p 24
###xml 202 209 202 209 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000473-g003">Fig. 3A</xref>
###xml 420 427 420 427 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000473-g003">Fig. 3A</xref>
###xml 558 565 558 565 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000473-g003">Fig. 3A</xref>
###xml 748 755 748 755 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000473-g003">Fig. 3B</xref>
###xml 1103 1110 1103 1110 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000473-g003">Fig. 3B</xref>
###xml 1203 1210 1203 1210 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000473-g003">Fig. 3B</xref>
To characterize the intracellular complexes containing PKR and NS1 protein, we fractionated lysates of A549 cells infected with the WT or NS1 mutant #4 virus by sucrose density gradient centrifugation (Fig. 3A). Immunoblot analysis of fractions 1 to 9 (top to bottom) showed that the NS1 WT, but not the dsRNA binding-deficient mutant protein co-sedimented with PKR and NP in higher order complexes in fractions 7 to 9 (Fig. 3A). Dot-blot analysis detected genomic viral RNA of the HA and NS segments in the same fractions, indicating the presence of vRNPs (Fig. 3A, panels "HA and NS vRNA"). As expected, control blots showed in lysates of mutant virus-infected cells the presence of phospho-PKR, whereas little activation occurred with WT virus (Fig. 3B, right panel, "lysate"). Since PKR co-sedimented with vRNP the question arose whether these factors interact and if this interaction could be involved in PKR activation. Therefore, we immunoprecipitated lysates of WT and mutant virus-infected cells with PKR-specific antibody and examined the precipitates by immunoblotting and RNA hybridization (Fig. 3B). Efficient co-precipitation of the wild-type NS1, but not the mutant protein was observed (Fig. 3B). We also detected the negative-stranded viral RNA, a major component of the viral RNP, in the precipitates without difficulty. Hence, these results indicate that PKR associates with viral RNP and, depending on intact dsRNA binding, also with the NS1 protein.
###end p 24
###begin title 25
NS1 WT but not dsRNA-binding deficient NS1 protein co-sediments with PKR and vRNP upon density gradient centrifugation.
###end title 25
###begin p 26
(A) A549 cells were infected with WT virus or mutant virus #4 at an MOI of 1. Cells were lyzed 12 hours p.i. and subjected to centrifugation through a continuous 5 to 50% sucrose gradient. 16 fractions were taken from top to bottom. Fractions 1 to 9 were analyzed by immunoblotting with antibodies specific for PKR and the viral NP and NS1 proteins. Also, RNA was extracted from gradient fractions 1 to 9 and was subjected to dot blot hybridization with probes specific for HA vRNA and NS vRNA, respectively (panels "HA and NS vRNA"). Whole cell lysates were analyzed by immunoblotting with antibodies specific for phospho-PKR, total PKR, viral NP, viral NS1 and tubulin as indicated (right panel,"lysate"). (B) A549 cells were mock treated or infected with WT virus or virus mutant #4 as described in panel A. Lysates were prepared and subjected to immunoprecipitation with anti-PKR (alpha) or control antibody (ctrl). The precipitated complexes were analyzed by immunoblotting for PKR and NS1 proteins. RNA was isolated from an identical set of PKR immunoprecipitates of cells infected with the mutant virus and subjected to dot blot analysis with an RNA-probe specific for HA vRNA.
###end p 26
###begin title 27
Activation of PKR correlates with cytoplasmic accumulation of vRNPs
###end title 27
###begin p 28
###xml 78 94 78 94 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">loss-of-function</italic>
###xml 183 189 183 189 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000473-g004">Fig. 4</xref>
###xml 395 402 395 402 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000473-g004">Fig. 4A</xref>
###xml 588 595 588 595 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000473-g004">Fig. 4A</xref>
###xml 760 767 760 767 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000473-g004">Fig. 4B</xref>
###xml 1072 1076 1072 1076 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000473-Elton1">[41]</xref>
###xml 1078 1085 1078 1085 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000473-g004">Fig. 4A</xref>
###xml 1193 1200 1193 1200 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000473-g004">Fig. 4B</xref>
###xml 1308 1315 1308 1315 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="ppat.1000473.s003">Fig. S3</xref>
Next, we compared the activation of PKR after infection of cells with the NS1 loss-of-function mutant #4 and WT virus in relation to the intracellular localization of vRNP complexes (Fig. 4). Confocal microscopy detected vRNPs as stained by NP-specific antibody in the nucleus at 8 hours post infection (p.i.), but increasing cytosolic signals appeared at 12 and 16 hours p.i. for both viruses (Fig. 4A). At the later time-points, the NS1 proteins were detected in the nuclear and the cytoplasmic compartments, although we noted a slightly stronger nuclear signal for the mutant protein (Fig. 4A). Starting at 12 hours p.i., the cytosolic appearance of vRNP was paralleled by detection of activated PKR in cells infected with the mutant, but not the WT virus (Fig. 4B). A similar picture was observed in cells infected with the delNS1 mutant virus (data not shown). Intriguingly, PKR activation by the mutant #4 virus was strongly reduced in the presence of leptomycin B (LMB), a fungal drug that specifically inhibits the CRM1 pathway and thus the nuclear export of vRNP [41] (Fig. 4A). Immunoblotting for NP, NS1 and tubulin showed comparable viral protein synthesis in the presence of LMB (Fig. 4B) and cell fraction analysis confirmed that LMB strongly reduced cytosolic NP levels under these condition (Fig. S3). These findings suggest that activation of PKR is associated with the cytosolic appearance of vRNPs late in infection.
###end p 28
###begin title 29
The nuclear egress of vRNPs late in infection leads to PKR activation.
###end title 29
###begin p 30
(A) A549 cells grown on glass cover slips were infected with WT or mutant virus #4 at an MOI of 1. Cells were mock treated or complemented with LMB starting at 3 hours p.i.. At 8, 12 and 16 hours p.i., cells were fixed and stained for NP (shown in red color), and also for the NS1 protein at the 16 h time-point (shown in green color). Microscopic sample analysis was conducted by confocal laser scanning microscopy. Scale bar, 10 microm. (B) A549 cells grown in culture dishes were infected with WT virus or mutant virus #4 at an MOI of 1. Cells were mock treated or complemented with LMB starting 3 hours p.i. and lyzed 8, 12 and 16 hours p.i.. Whole cell lysates were analyzed by immunoblotting with antibodies specific for phospho-PKR, total PKR, NP, NS1 and tubulin as indicated.
###end p 30
###begin title 31
###xml 48 56 48 56 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
Purified viral RNPs trigger PKR kinase activity in vitro
###end title 31
###begin p 32
###xml 120 127 120 127 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="ppat.1000473.s002">Fig. S2</xref>
###xml 402 404 398 400 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">32</sup>
###xml 465 472 461 468 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000473-g005">Fig. 5A</xref>
###xml 810 817 806 813 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000473-g005">Fig. 5A</xref>
###xml 1041 1048 1037 1044 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000473-g005">Fig. 5A</xref>
###xml 1225 1232 1221 1228 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000473-g005">Fig. 5B</xref>
###xml 1363 1366 1359 1362 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000473-Garcia1">[3]</xref>
###xml 1572 1576 1568 1572 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000473-Regan1">[42]</xref>
To test the hypothesis that influenza virus RNP activates PKR directly, we purified vRNPs from influenza B/Lee virions (Fig. S2) and tested them for stimulation of PKR autophosphorylation. V5 epitope-tagged PKR was expressed in 293T cells and precipitated from cell lysate with tag-specific antibody. Activation of the precipitated kinase in the presence of vRNP was assessed by incubation with [gamma-32P]-ATP followed by analysis on SDS gels and autoradiography. Fig. 5A shows an exposure of autophosphorylated PKR (lanes "32P-PKR") and the same region of the gel after staining with Coomassie Blue (Lanes "PKR-V5", "NP" and "IgG"). Interestingly, the purified vRNP stimulated PKR autophosphorylation in a dose-dependent manner similar to the synthetic dsRNA polyriboinosinic: polyribocytidylic acid (pI:C) (Fig. 5A). Pre-treatment of vRNP with either dsRNA-specific RNase III or ssRNA-specific RNase I prior to the kinase reaction abolished PKR activation, which argues against the presence of a protein activator of PKR in the reaction (Fig. 5A). Significantly, influenza virus RNP hardly activated the dsRNA binding-deficient PKR-K60A mutant, further confirming the dsRNA-dependency of vRNP-mediated kinase stimulation (Fig. 5B). Control reactions showed that the PKR-K60A mutant enzyme was activated by heparin, a common trigger for PKR autophosphorylation [3], excluding the possibility that the mutation affected general kinase activity. We note that influenza virions package only RNPs containing negative-stranded genomic RNA and not complementary nucleic acids [42], which could induce double-stranded hybrids. Moreover, the kinase assay conditions used prevented the viral polymerase from transcribing complementary RNA, which could hypothetically induce duplex RNA.
###end p 32
###begin title 33
###xml 53 61 53 61 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
Purified viral RNP activates PKR autophosphorylation in vitro.
###end title 33
###begin p 34
###xml 183 185 175 177 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">32</sup>
(A) V5-tagged PKR was expressed in 293T cells and precipitated from lysate by anti-V5 antibody. Kinase activation was assayed on precipitated PKR in the presence of 10 microCi [gamma-32P]ATP for 30 min at 30degreesC. PKR was activated as indicated by 2.5, 5 or 7.5 microl vRNP, or 2.5 ng/microl pI:C. In further reactions, 5 microl vRNP were pre-treated with 5 U RNase III or 5 U RNase I, respectively. Kinase reactions were analyzed by SDS gel electrophoresis and autoradiography (upper panel). Autophosphorylation of PKR was evaluated using the AIDA software and is given as fold activation compared to mock treated PKR. The values represent the average of three independent experiments. Error bars indicate the standard deviation. After exposure the SDS gel was stained with Coomassie blue to visualize precipitated V5-PKR, NP and the IgG heavy chain (lower panel). (B) V5-tagged PKR and V5-tagged mutant PKR-K60A that does not bind dsRNA were expressed in 293T cells, precipitated and stimulated in the autophosphorylation assay by vRNP or treatment with heparin as indicated. Quantification was done as described in panel A. (C) V5-tagged PKR was expressed in 293T cells, precipitated and subjected to the kinase activation assay as described above. PKR was incubated as indicated without or with 0.3, 1.0 or 3.0 microM of a transcribed model vRNA of 53 nucleotides, which was mock-treated or dephosphorylated by phosphatase, respectively, as indicated.
###end p 34
###begin p 35
###xml 136 140 136 140 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000473-Nallagatla1">[43]</xref>
###xml 588 595 588 595 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000473-g005">Fig. 5C</xref>
###xml 677 680 677 680 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">via</italic>
It is difficult to determine whether the removal of the 5'-triphosphate group on the vRNA within the native RNP reduces PKR stimulation [43]. Phosphatase not only hydrolyzes the 5'-triphosphate, but also removes the phosphate groups on activated PKR and the donor nucleotide, and a subsequent elimination of the phosphatase by phenol extraction would obstruct RNP structure. However, we showed that phosphatase treatment strongly reduced activation of PKR by synthetic influenza virus model vRNA containing the terminal 5'- and 3'- ends, indicating a contribution of the 5'-triphosphate (Fig. 5C). In conclusion, these experiments suggest that influenza virus RNP, most likely via structured regions within the genomic RNA and its unmodified 5'-end, activates PKR.
###end p 35
###begin title 36
Discussion
###end title 36
###begin p 37
###xml 96 104 96 104 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 109 116 109 116 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 411 415 407 411 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000473-Dauber1">[16]</xref>
###xml 868 871 864 867 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 865 871 861 867 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PKR<sup>&#8722;/&#8722;</sup></italic>
###xml 1081 1085 1077 1081 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000473-Min1">[32]</xref>
###xml 1220 1223 1216 1219 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 1217 1223 1213 1219 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PKR<sup>+/+</sup></italic>
###xml 1231 1234 1227 1230 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1228 1234 1224 1230 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PKR<sup>&#8722;/&#8722;</sup></italic>
###xml 1303 1307 1299 1303 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">null</italic>
###xml 1313 1317 1309 1313 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000473-Bergmann1">[15]</xref>
###xml 1561 1565 1557 1561 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000473-Schneider1">[38]</xref>
###xml 78 95 <span type="species:ncbi:11520">influenza B virus</span>
###xml 781 785 <span type="species:ncbi:10090">mice</span>
###xml 872 876 <span type="species:ncbi:10090">mice</span>
###xml 999 1016 <span type="species:ncbi:11320">influenza A virus</span>
###xml 1235 1239 <span type="species:ncbi:10090">mice</span>
###xml 1308 1312 <span type="species:ncbi:10090">mice</span>
The present study showed that PKR is a major factor restricting the growth of influenza B virus in vitro and in vivo and revealed mechanisms for its activation and subversion. We previously reported that mutational inactivation of the dsRNA binding domain of the B/NS1 protein attenuated viral replication and ablated the control of PKR and eIF2alpha phosphorylation, but only slightly affected IFN suppression [16]. Our new analysis firmly establishes that the key activity of the B/NS1 dsRNA binding domain is to silence PKR and excludes the possibility that another antiviral factor(s) is chiefly responsible for the observed growth defects of the mutants: The absence of PKR restored a virulent phenotype of the mutant viruses expressing dsRNA binding-deficient NS1 protein in mice and viral titers were elevated to the range of wild-type virus in the lungs of PKR-/- mice and fibroblasts. Interestingly, this is slightly different to a reported main function of the dsRNA binding domain of the influenza A virus NS1 protein in targeting the antiviral 2'-5'-OAS/RNase L system [32]. Our study revealed a further distinction between type A and B influenza viruses since the B/delNS1 virus behaved benignly in both PKR+/+ and PKR-/- mice, whereas a comparable A/delNS1 virus regained virulence in PKR null mice [15]. This finding points to the existence of an additional important function of the B/NS1 protein during viral replication, which is possibly related to its recently reported activity in modifying the nuclear speckle compartment of the host cell [38].
###end p 37
###begin p 38
###xml 133 151 133 151 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">loss-of-inhibition</italic>
###xml 321 325 321 325 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000473-Weber1">[10]</xref>
###xml 831 839 831 839 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 1383 1391 1383 1391 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 1391 1395 1391 1395 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000473-Zheng1">[44]</xref>
###xml 1630 1634 1630 1634 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000473-Hsu1">[45]</xref>
###xml 1635 1639 1635 1639 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000473-Klumpp1">[47]</xref>
###xml 1655 1659 1655 1659 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000473-Palese1">[11]</xref>
###xml 1743 1747 1743 1747 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000473-Palese1">[11]</xref>
###xml 1840 1844 1840 1844 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000473-Nallagatla1">[43]</xref>
The interactions of PKR with its RNA effectors and viral inhibitors are complex and incompletely understood. Our analysis of defined loss-of-inhibition mutant viruses offers new insights into the conundrum of how dsRNA-dependent PKR is activated during infection by influenza virus that does not generate long duplex RNA [10]. Based on several lines of evidence, we put forward the hypothesis that influenza virus RNP functions as a non-canonical activator of PKR in the cytosol: First, PKR autophosphorylation in infected cells occurred concomitantly with the cytosolic appearance of vRNP, when a functional NS1 protein was absent. Second, PKR activation was largely abolished when the nucleo-cytoplasmic export of vRNP was blocked by LMB treatment. Third, biochemical analysis demonstrated that purified vRNP activates PKR in an in vitro kinase assay directly. The RNA-dependency of this stimulation was shown by its sensitivity to pre-treatment with single- and double-strand-specific RNases and the failure of the vRNP to activate a dsRNA binding-defective PKR. We favour the explanation that the vRNA promoter structure formed by the partially complementary 5'- and 3'-ends within vRNP is an important determinant for PKR activation. Synthetic A-form RNA consisting of a short stem region flanked by single-stranded nucleotides was previously shown to efficiently stimulate PKR in vitro[44]. There is now ample evidence from structural, biochemical and functional studies that the 14-16 nucleotides of the vRNA termini engage in base-pairing interactions and exist in form of a panhandle and/or a related corkscrew structure [45]-[47] (summarized in [11]). Intriguingly, the 5'-ends of influenza virus RNAs carry a triphosphate structure [11] and this chemical group was recently reported to support activation of PKR by stem-loop RNA [43]. In fact, the present study is the first characterization of a natural viral RNA/RNP with a 5'-triphosphate group that triggers PKR, as the studies mentioned above tested exclusively synthetic model RNAs. Our mechanistic model suggests PKR can contact RNA residues within the vRNP despite their association with the viral NP and polymerase proteins.
###end p 38
###begin p 39
###xml 304 307 304 307 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000473-Pichlmair1">[9]</xref>
###xml 308 312 308 312 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000473-Dauber1">[16]</xref>
###xml 313 317 313 317 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000473-Hornung1">[48]</xref>
###xml 961 964 961 964 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000473-Pichlmair1">[9]</xref>
###xml 965 969 965 969 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000473-Dauber1">[16]</xref>
###xml 970 974 970 974 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000473-Hornung1">[48]</xref>
###xml 1342 1346 1342 1346 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000473-Min2">[49]</xref>
###xml 1347 1351 1347 1351 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000473-Tan1">[50]</xref>
###xml 68 85 <span type="species:ncbi:11520">influenza B virus</span>
###xml 1181 1198 <span type="species:ncbi:11520">influenza B virus</span>
A second novel aspect of our study centres on the mode by which the influenza B virus NS1 protein inhibits PKR. Previously, we showed that dsRNA binding mutations within NS1 prevented PKR inhibition, but did not eliminate the suppression of IFN induction that is triggered through the RNA helicase RIG-I [9],[16],[48]. Our new study explains the former observation by showing that the NS1 protein entangles PKR into an immunoprecipitable complex in infected cells. These PKR-NS1 complexes were sensitive to treatment with dsRNA-specific RNase and the interaction required a functional NS1 dsRNA binding domain. The most likely interpretation of these findings is that RNA to which both proteins bind facilitates the interaction of PKR and NS1. Interestingly, the association with PKR appears to be necessary but not sufficient to preclude its activation. In fact, all NS1 mutants that were not associated with PKR failed to block kinase activation (this study; [9],[16],[48]), but the NS1 mutant #1 did not prevent PKR activation even though it interacted with the enzyme. Clearly, more work is required to determine the whole catalogue of events leading to the blockade of PKR by influenza B virus. Slightly different modes of PKR association, which did not require dsRNA binding in GST pull-down assays were suggested for the A/NS1 protein [49],[50]. We have therefore initiated comparative studies to determine whether the two divergent NS1 proteins employ different or similar ways to block PKR.
###end p 39
###begin p 40
###xml 96 113 <span type="species:ncbi:11520">influenza B virus</span>
At present, we can only speculate about the nature of the RNA component in NS1-PKR complexes in influenza B virus-infected cells. The presented data argue for a scenario in which cytoplasmic vRNP complexes are recognized by PKR and provide the major stimulus for its activation. We detected both vRNA and the NS1 protein in PKR immunoprecipitates from infected cell lysate raising the possibility that NS1 prohibits activation of PKR by cytosolic vRNP through the formation of a hetero-trimeric complex. However, we cannot rule out the option that binding of NS1 to PKR in infected cells is mediated by a yet undetermined viral or host-derived nucleic acid; for that reason more work will be required to elucidate the specific components involved.
###end p 40
###begin p 41
###xml 143 149 143 149 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000473-g006">Fig. 6</xref>
###xml 272 279 272 279 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000473-g006">Fig. 6A</xref>
###xml 536 543 536 543 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000473-g006">Fig. 6B</xref>
###xml 752 759 752 759 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000473-g006">Fig. 6C</xref>
###xml 970 974 970 974 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000473-Schneider1">[38]</xref>
###xml 1168 1172 1168 1172 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000473-Dauber1">[16]</xref>
###xml 1173 1177 1173 1177 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000473-Hatada1">[17]</xref>
###xml 1178 1182 1178 1182 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000473-Ludwig2">[51]</xref>
###xml 4 21 <span type="species:ncbi:11520">influenza B virus</span>
The influenza B virus non-structural NS1 protein has apparently evolved in a way that suits the specific needs of the pathogen to inhibit PKR (Fig. 6). During the first hours of infection viral RNPs are confined to the nucleus and not accessible for the cytosolic sensor (Fig. 6A). At later stages, the vRNPs are exported to the cytoplasm where they assemble into progeny virions at the plasma membrane. Cytoplasmic vRNPs act as PKR activators in the absence of functional NS1 protein, thus reducing protein synthesis and virus growth (Fig. 6B). However, in the wild-type situation NS1 protein is expressed and prevents activation of PKR by vRNPs, thereby facilitating full-level synthesis of structural viral proteins and efficient viral propagation (Fig. 6C). This scenario is supported by the dynamic intracellular trafficking of the B/NS1 protein showing that it migrates to nuclear speckles early in infection, but relocalizes to the cytoplasm at later time-points [38]. The model may also explain phenotypes of mutant influenza viruses with lesions in the NS1 protein that activate PKR and show a selective reduction in the synthesis of late viral gene products [16],[17],[51].
###end p 41
###begin title 42
Model for the induction and inhibition of antiviral PKR by influenza virus.
###end title 42
###begin p 43
The three panels show the localization of the genomic vRNA/RNP complexes with structured 5'- and 3'-ends together with the phosphorylation status of PKR in early (panel A) and late phases (panels B and C) of virus infection. Viral RNP is located in the nucleus early in infection and is not accessible for cytosolic PKR (panel A). Upon nuclear export at later stages, vRNP complexes stimulate PKR activation in the absence of functional NS1 protein, leading to an inhibition of viral proteins synthesis and replication (panel B). However, the presence of functional viral NS1 protein suppresses this antiviral reaction thereby supporting high-level viral propagation (panel C).
###end p 43
###begin p 44
###xml 356 368 356 368 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Bunyaviridae</italic>
###xml 402 406 402 406 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000473-Schmaljohn1">[52]</xref>
###xml 513 517 509 513 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000473-Streitenfeld1">[53]</xref>
###xml 766 777 762 773 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Filoviridae</italic>
###xml 830 834 826 830 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000473-Feng1">[54]</xref>
###xml 922 935 918 931 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Rhabdoviridae</italic>
###xml 980 984 976 980 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000473-Stojdl1">[55]</xref>
###xml 1373 1376 1369 1372 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">via</italic>
###xml 1651 1655 1647 1651 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000473-Basu1">[56]</xref>
###xml 496 512 <span type="species:ncbi:35304">Bunyamwera virus</span>
###xml 667 678 <span type="species:ncbi:205488">Ebola virus</span>
###xml 878 904 <span type="species:ncbi:11276">vesicular stomatitis virus</span>
###xml 975 979 <span type="species:ncbi:10090">mice</span>
Finally, we suggest that activation of PKR by other negative strand RNA viruses that generate little or no detectable long duplex RNA may occur in a similar way. The genomes of many of these viruses enter the cytoplasm as part of an RNP structure and carry a 5'-triphosphate group. In fact, the conserved ends of the genomic RNAs of several members of the Bunyaviridae also form a structured panhandle [52] and the level of phosphorylated eIF2alpha increased during infection with the prototypic Bunyamwera virus [53]. Further observations suggest that also non-segmented negative-strand RNA viruses may induce PKR by a ribonucleoprotein structure; for instance, the Ebola virus VP35 protein counteracts stimulation of PKR, indicating indirectly that members of the Filoviridae family activate and prevent induction of the kinase [54]. In addition, replication and virulence of vesicular stomatitis virus, a member of the Rhabdoviridae, is strongly enhanced in PKR-deficient mice [55]. Exploring the methods used by viral pathogens to counteract PKR not only promises an improved understanding of the innate immune defense against viral infections, but may also foster the development of novel therapeutic substances. Our study suggests that it should be possible to shift the course of influenza virus infection from efficient pathogen replication towards its elimination via the body's innate defense if the NS1-mediated blockade of PKR could be suspended. The recent description of substances capable to modulate NS1's activity in IFN suppression supports the concept that this viral protein is indeed amenable to control by therapeutic substances [56].
###end p 44
###begin title 45
Materials and Methods
###end title 45
###begin title 46
Cells and viruses
###end title 46
###begin p 47
###xml 125 126 125 126 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">l</sc>
###xml 310 313 310 313 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PKR</italic>
###xml 313 316 313 316 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 352 355 352 355 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PKR</italic>
###xml 355 358 355 358 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 360 364 360 364 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000473-Yang1">[39]</xref>
###xml 418 419 418 419 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">l</sc>
###xml 515 516 502 503 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 717 721 700 704 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000473-Dauber1">[16]</xref>
###xml 722 726 705 709 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000473-Dauber2">[20]</xref>
###xml 780 783 763 766 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PKR</italic>
###xml 783 786 766 769 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 790 793 773 776 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PKR</italic>
###xml 793 796 776 779 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1101 1105 1074 1078 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000473-Dauber2">[20]</xref>
###xml 102 106 <span type="species:ncbi:9913">calf</span>
###xml 304 308 <span type="species:ncbi:10090">mice</span>
###xml 321 325 <span type="species:ncbi:10090">mice</span>
###xml 912 918 <span type="species:ncbi:9913">bovine</span>
293T and A549 cells were grown in Dulbecco's modified Eagle medium (DMEM) supplemented with 10% fetal calf serum (FCS), 2 mM l-glutamine, and antibiotics. Madin-Darby canine kidney (MDCK) type II cells were grown in minimal essential medium (MEM) with the same additives. MEFs were prepared from C57BL/6 mice (PKR+/+) or mice devoid of functional PKR (PKR-/-) [39] and cultured in DMEM supplemented with 10% FCS, 2 mM l-glutamine and 50 microM beta-mercaptoethanol. All cells were maintained at 37degreesC and 5% CO2. The recombinant influenza B/Lee WT and mutant viruses DeltaNS1, NS1 33/38 (#1), NS1 47/50 (#2), NS1 52/53/54 (#3), NS1 58/60/64 (#4), NS1 77/78 (#6), and NS1 83/86 (#7) have been described elsewhere [16],[20]. To analyze viral replication, monolayer cultures of PKR+/+ or PKR-/- MEFs were infected at a multiplicity of infection (MOI) of 0.1 and incubated at 33degreesC in DMEM containing 0.2% bovine albumin and 0.5 microg/ml trypsin. Virus titers were determined by indirect immunofluorescence staining and were expressed as fluorescence-forming units (ffu)/ml as described before [20].
###end p 47
###begin title 48
###xml 14 18 <span type="species:ncbi:10090">mice</span>
Infections of mice
###end title 48
###begin p 49
###xml 42 45 42 45 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 39 45 39 45 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PKR<sup>+/+</sup></italic>
###xml 53 56 53 56 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 50 56 50 56 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PKR<sup>&#8722;/&#8722;</sup></italic>
###xml 108 112 108 112 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000473-Yang1">[39]</xref>
###xml 222 223 218 219 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sup>
###xml 57 61 <span type="species:ncbi:10090">mice</span>
###xml 315 319 <span type="species:ncbi:10090">mice</span>
###xml 374 378 <span type="species:ncbi:10090">Mice</span>
###xml 486 503 <span type="species:ncbi:11520">influenza B virus</span>
###xml 604 608 <span type="species:ncbi:10090">mice</span>
###xml 808 812 <span type="species:ncbi:10090">Mice</span>
Eight-week-old female wild type C57BL6 PKR+/+ and PKR-/- mice with the mixed 129/Sv(ev)xC57BL/6J background [39] were anesthetized and infected intranasally with 50 microl of phosphate-buffered saline (PBS) containing 1x105 ffu of the indicated recombinant influenza B/Lee viruses. For viral lung titrations, three mice were sacrificed at day 3 and at day 6 post-infection. Mice lungs were homogenized in 1 ml PBS, and titrated by immunofluorescence using a monoclonal antibody against influenza B virus nucleoprotein (Abcam; ab20711-100). Comparison of viral lung titers in WT and mutant virus-infected mice at each time-point was done using the Student's t test for pairwise comparisons. For monitoring of viral disease, 8 animals were weighed daily for two weeks and euthanized when observed in extremis. Mice were bred and maintained at the Mount Sinai School of Medicine in accordance with Federal and university guidelines.
###end p 49
###begin title 50
Plasmids
###end title 50
###begin p 51
###xml 58 63 <span type="species:ncbi:9606">human</span>
pcDNA3.1-PKR-V5/His was constructed by integration of the human PKR cDNA into the vector pcDNA3.1-V5/His (Invitrogen). The derived pcDNA3.1-PKR-K60A-V5/His plasmid was constructed with the QuikChange mutagenesis kit (Stratagene). The integrity of the constructs was confirmed by DNA cycle sequencing.
###end p 51
###begin title 52
Immunoprecipitation and immunoblot analysis
###end title 52
###begin p 53
###xml 6 7 6 7 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sup>
###xml 269 270 262 263 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 272 273 265 266 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sub>
###xml 438 442 425 429 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000473-Dauber1">[16]</xref>
###xml 702 703 689 690 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 757 758 741 742 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 760 761 744 745 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sub>
###xml 421 427 <span type="species:ncbi:9986">rabbit</span>
###xml 835 841 <span type="species:ncbi:9986">rabbit</span>
###xml 1059 1065 <span type="species:ncbi:9986">rabbit</span>
###xml 1077 1082 <span type="species:ncbi:10090">mouse</span>
###xml 1121 1127 <span type="species:ncbi:9986">rabbit</span>
###xml 1159 1164 <span type="species:ncbi:10090">mouse</span>
###xml 1197 1203 <span type="species:ncbi:9986">rabbit</span>
###xml 1257 1262 <span type="species:ncbi:10090">mouse</span>
###xml 1316 1327 <span type="species:ncbi:3704">horseradish</span>
2.5x106 A549 cells were mock-treated or infected with WT, DeltaNS1 or NS1 mutant virus at an MOI of 1. Cell extracts were prepared 8 hours p.i. in IP lysis buffer (1% Igepal-CA 630, 150 mM NaCl, 20 mM Tris.HCl, pH 7.5, 1 mM EDTA, 10 mM Na-beta-glycerophosphate, 2 mM Na3VO4, 1 mM Pefabloc). When indicated, lysates were pre-incubated with RNase III (Ambion) for 10 min at 33degreesC before incubation with B/NS1-specific rabbit antiserum [16]. Immune complexes were collected on protein-G-agarose beads (Roche), washed and the precipitated proteins were dissolved in SDS sample buffer. For PKR immunoprecipitation cells were lyzed in kinase binding buffer (20 mM Hepes pH 7.5, 300 mM NaCl, 5 mM Mg(OAc)2, 10% glycerol, 25 mM Na-beta-glycerophosphat, 2 mM Na3VO4, 1 mM Pefabloc) containing 0.5% Igepal-CA 630. PKR was precipitated with rabbit anti-PKR antibody (Epitomics) and immunocomplexes were collected as described above. The precipitated proteins were analyzed as indicated by SDS gel electrophoresis and immunoblotting using the primary B/NS1-specific rabbit antiserum, mouse anti-PKR antibody 71/10 (Ribogene) or rabbit anti-PKR antibody (Epitomics), mouse anti-NP antibody (AbD Serotec), rabbit anti-phospho-PKR (Thr446) antibody (Cell Signaling), mouse anti-tubulin antibody (Sigma) and suitable secondary horseradish peroxidase (HRP)-conjugated IgG together with an enhanced chemiluminiscence protocol (Pierce). To detect PKR-associated viral nucleic acids, the PKR immunoprecipitate was subjected to proteinase K digestion and phenol extraction. Purified RNA was subjected to dot blot analysis with probes specific for HA vRNA as described below.
###end p 53
###begin title 54
Density gradient centrifugation
###end title 54
###begin p 55
###xml 6 7 6 7 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sup>
###xml 221 222 215 216 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 280 281 271 272 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 283 284 274 275 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sub>
2.5x106 A549 cells were mock-treated or infected with B/Lee WT or NS1 58/60/64 (#4) mutant virus at an MOI of 1 at 33degreesC. Cells were lyzed 12 hours p.i. in LyP-100 buffer (25 mM Hepes pH 7.5, 100 mM NaCl, 2.5 mM MgCl2, 0.1% Igepal-CA 630, 10 mM beta-glycerophosphate, 2 mM Na3VO4, 1 mM Pefabloc, 5 microl/ml RNasin). Lysates were loaded onto a continuous sucrose gradient (5 to 50% in LyP-100 buffer) and centrifuged in a SW60Ti rotor (Beckman) for 150 minutes at 30.000 rpm and 4degreesC. Sixteen 250 microl fractions were taken from top to bottom. Fractions 1 to 9 were halved and analyzed by immunoblotting or subjected to RNA extraction (RNeasy, Qiagen), respectively. Denatured extracted RNA in 7.5% formaldehyde and 10xSSC were dotted onto Nylon transfer membrane and NS and HA vRNAs were detected with segment-specific DIG-labeled probes. DIG-labelled probes were generated from linearized template DNA by T7 RNA polymerase-mediated transcription using the DIG Northern Starter Kit (Roche).
###end p 55
###begin title 56
Leptomycin B (LMB) treatment of infected cells
###end title 56
###begin p 57
###xml 4 5 4 5 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sup>
###xml 493 500 493 500 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="ppat.1000473.s004">Text S1</xref>
###xml 753 758 <span type="species:ncbi:10090">mouse</span>
###xml 804 808 <span type="species:ncbi:9925">goat</span>
###xml 814 819 <span type="species:ncbi:10090">mouse</span>
1x106 A549 cells were either mock-treated of infected with B/Lee WT or NS1 58/60/64 (#4) mutant virus at an MOI of 1. 7.5 ng/ml LMB (Sigma) or an equal volume of 70% methanol as a solvent control was added to the supernatant at 3 hours p.i.. At 8, 12 and 16 hours p.i. cells were lyzed in kinase binding buffer containing 0.5% Igepal-CA 630 and were analyzed by immunoblotting, as described above. The fractionation of cell lysate is described in the supporting materials and methods section (Text S1). In parallel, A549 cells grown on glass coverslips were infected and treated with LMB as described above. The cells were fixed with 2.5% paraformaldehyde and permeabilized with 0.2% Triton X-100 at 8, 12 or 16 hours. Viral NP was stained with primary mouse anti-NP antibody (AbD Serotec) and secondary goat anti-mouse Alexa 594 antibody (Molecular Probes). Cells were not stained for PKR as the available antibody appeared to be not suitable. Cells were analyzed with a LSM510 Meta confocal laser scanning microscope (Zeiss, Jena, Germany) equipped with a 63x/1.2 water objective lens. Data were analyzed and processed by the LSM Image Browser 3.5 and Adobe Photoshop 4.0 software packages.
###end p 57
###begin title 58
PKR autophosphorylation assay
###end title 58
###begin p 59
###xml 4 5 4 5 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sup>
###xml 441 442 441 442 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 453 454 453 454 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 604 606 589 591 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">32</sup>
###xml 621 622 606 607 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 624 625 609 610 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sub>
###xml 751 758 736 743 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="ppat.1000473.s004">Text S1</xref>
###xml 1398 1402 1363 1367 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000473-Parvin1">[57]</xref>
###xml 1421 1426 1386 1391 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MboII</italic>
###xml 1560 1568 1519 1527 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 213 218 <span type="species:ncbi:10090">mouse</span>
###xml 801 818 <span type="species:ncbi:11520">influenza B virus</span>
5x106 293T cells were transfected with pcDNA3.1-PKR-V5/His or pcDNA3.1-PKR-K60A-V5/His, respectively. Cells were lyzed in kinase binding buffer containing 0.5% Igepal-CA 630, the cleared lysate was incubated with mouse anti-V5 antibody (AbD Serotec) and immunocomplexes were collected on protein G-agarose. The beads were washed twice with kinase binding buffer and twice with kinase assay buffer (20 mM Hepes pH 7.5, 50 mM KCl, 2 mM Mg(OAc)2, 2 mM MnCl2, 25 mM Na-beta-glycerophosphat). The activation assay was performed on immobilized PKR in kinase assay buffer with 250 microM ATP, 10 microCi [gamma-32P]-ATP, 5 mM Na3VO4, 1 mM NaF, 1 mM DTT. Viral RNPs were purified from detergent-treated virions as described in the supporting methods section (Text S1). PKR was activated by addition of pooled influenza B virus vRNP fraction, 2.5 ng/microl poly I:C (Sigma) or 12.5 ng/microl heparin (Sigma), respectively, and incubated for 30 min at 30degreesC. Autophosphorylated PKR was analyzed by 10% SDS-PAGE and visualized by autoradiography. Densitometric evaluation was done with the AIDA 4.18.028 software and is given as fold activation compared to mock-treated PKR. For RNase treatment, vRNPs were incubated for 15 min at 37degreesC alone or with 5 U RNase III (Ambion) or 5 U RNase I (Ambion), respectively, prior to the kinase reaction. For PKR activation by synthetic vRNA, the plasmid pV-WT [57] was digested with MboII (Fermentas), treated with Klenow fragment (Fermentas) for 10 min at 37degreesC and used as a template for T7 RNA polymerase mediated in vitro transcription. The 53 nt long model vRNA containing the terminal 5' and 3' end sequences of influenza virus NS segment connected by a short linker was purified by a Quick Spin Oligo Column (Roche) and mock-treated or treated with Antarctic phosphatase (NEB) for 30 min at 37degreesC. The phosphatase was inactivated at 65degreesC for 15 min. vRNAs were purified by phenol/chloroform extraction and ethanol precipitation and concentrations were determined by UV spectroscopy. Precipitated PKR was incubated with mock-treated or phosphatase-treated vRNA for 30 min at 30degreesC. Autophosphorylation of PKR and densitometric analyses were done as described above.
###end p 59
###begin title 60
Supporting Information
###end title 60
###begin p 61
###xml 100 108 100 108 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PKR null</italic>
###xml 154 157 154 157 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 236 237 236 237 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sup>
###xml 550 553 550 553 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 109 113 <span type="species:ncbi:10090">mice</span>
###xml 178 182 <span type="species:ncbi:10090">mice</span>
###xml 283 292 <span type="species:ncbi:11601">Lee virus</span>
###xml 478 482 <span type="species:ncbi:10090">Mice</span>
###xml 554 558 <span type="species:ncbi:10090">mice</span>
Pathogenicity of influenza B viruses expressing dsRNA-binding defective NS1 proteins is enhanced in PKR null mice. (A) Groups of eight-week-old female PKR-/- and wild type C57B6 mice were anesthetized and infected intranasally with 1x105 pfu of the indicated recombinant influenza B/Lee virus. For monitoring of viral disease, 8 animals were weighed daily for two weeks, and mean percentage weight loss of each group was compared with the weight immediately prior to infection. Mice were euthanized when observed in extremis. (B) Survival rate of PKR-/- mice after infection with recombinant influenza B viruses. Dead animals were scored daily and represented as the percentage of surviving animals.
###end p 61
###begin p 62
(0.18 MB TIF)
###end p 62
###begin p 63
Click here for additional data file.
###end p 63
###begin p 64
###xml 202 209 202 209 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="ppat.1000473.s004">Text S1</xref>
###xml 50 59 <span type="species:ncbi:11601">Lee virus</span>
###xml 92 99 <span type="species:ncbi:9031">chicken</span>
Preparation of vRNPs from recombinant influenza B/Lee virus. Virus was grown in embryonated chicken eggs and subjected to lysis and centrifugation over a discontinuous glycerol gradient as described in Text S1. Fractions were taken from top to bottom and analyzed by SDS-PAGE and Coomassie blue staining (upper panel) and immunblotting with NP specific antibody (middle panel). RNA was extracted from the fractions and subjected to reverse transcription (RT)-PCR with primers specific for the vRNA of the NS segment (lower panel).
###end p 64
###begin p 65
(0.58 MB TIF)
###end p 65
###begin p 66
Click here for additional data file.
###end p 66
###begin p 67
Treatment of infected cells with LMB inhibits the nuclear export of NP. A549 cells were infected with influenza B/Lee WT virus at an MOI of 1. Cells were mock treated or complemented with LMB starting at 3 hrs p.i.. Cells were lyzed at 15 hrs p.i. and cytoplasmic (C.) and nuclear fractions (N.) were generated. The fractions were analyzed by immunoblotting for viral NP and the marker antigens for the nuclear and cytoplasmic fractions, PARP and tubulin, respectively.
###end p 67
###begin p 68
(0.11 MB TIF)
###end p 68
###begin p 69
Click here for additional data file.
###end p 69
###begin p 70
This file contains supporting materials and methods.
###end p 70
###begin p 71
(0.03 MB DOC)
###end p 71
###begin p 72
Click here for additional data file.
###end p 72
###begin p 73
We thank Gudrun Heins, Andrea Zoehner and Richard Cadagan for excellent technical support and Lesley Ogilvie for writing assistance.
###end p 73
###begin title 74
References
###end title 74
###begin article-title 75
Type 1 interferons and the virus-host relationship: a lesson in detente.
###end article-title 75
###begin article-title 76
Structure and function of the protein kinase R.
###end article-title 76
###begin article-title 77
Impact of protein kinase PKR in cell biology: from antiviral to antiproliferative action.
###end article-title 77
###begin article-title 78
###xml 46 51 <span type="species:ncbi:9606">human</span>
Molecular cloning and characterization of the human double-stranded RNA-activated protein kinase induced by interferon.
###end article-title 78
###begin article-title 79
###xml 152 157 <span type="species:ncbi:9606">human</span>
Mechanism of interferon action: functional characterization of positive and negative regulatory domains that modulate transcriptional activation of the human RNA-dependent protein kinase Pkr promoter.
###end article-title 79
###begin article-title 80
Molecular mechanisms of interferon resistance mediated by viral-directed inhibition of PKR, the interferon-induced protein kinase.
###end article-title 80
###begin article-title 81
Interactions between double-stranded RNA regulators and the protein kinase DAI.
###end article-title 81
###begin article-title 82
When two strands are better than one: the mediators and modulators of the cellular responses to double-stranded RNA.
###end article-title 82
###begin article-title 83
RIG-I-mediated antiviral responses to single-stranded RNA bearing 5'-phosphates.
###end article-title 83
###begin article-title 84
Double-stranded RNA is produced by positive-strand RNA viruses and DNA viruses but not in detectable amounts by negative-strand RNA viruses.
###end article-title 84
###begin article-title 85
###xml 0 16 0 16 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Orthomyxoviridae</italic>
Orthomyxoviridae: The viruses and their replication.
###end article-title 85
###begin article-title 86
Viral double-stranded RNA, cytokines, and the flu.
###end article-title 86
###begin article-title 87
Functional characterization of and cooperation between the double-stranded RNA-binding motifs of the protein kinase PKR.
###end article-title 87
###begin article-title 88
###xml 15 32 <span type="species:ncbi:11320">influenza A virus</span>
Binding of the influenza A virus NS1 protein to PKR mediates the inhibition of its activation by either PACT or double-stranded RNA.
###end article-title 88
###begin article-title 89
Influenza virus NS1 protein counteracts PKR-mediated inhibition of replication.
###end article-title 89
###begin article-title 90
###xml 31 48 <span type="species:ncbi:11520">influenza B virus</span>
Double-stranded RNA binding of influenza B virus nonstructural NS1 protein inhibits protein kinase R but is not essential to antagonize production of alpha/beta interferon.
###end article-title 90
###begin article-title 91
Mutant influenza viruses with a defective NS1 protein cannot block the activation of PKR in infected cells.
###end article-title 91
###begin article-title 92
Conserved surface features form the double-stranded RNA binding site of non-structural protein 1 (NS1) from influenza A and B viruses.
###end article-title 92
###begin article-title 93
The RNA-binding and effector domains of the viral NS1 protein are conserved to different extents among influenza A and B viruses.
###end article-title 93
###begin article-title 94
###xml 4 21 <span type="species:ncbi:11520">influenza B virus</span>
The influenza B virus nonstructural NS1 protein is essential for efficient viral growth and antagonizes beta interferon induction.
###end article-title 94
###begin article-title 95
###xml 52 69 <span type="species:ncbi:11520">influenza B virus</span>
The N- and C-terminal domains of the NS1 protein of influenza B virus can independently inhibit IRF-3 and beta interferon promoter activation.
###end article-title 95
###begin article-title 96
###xml 4 21 <span type="species:ncbi:11320">influenza A virus</span>
The influenza A virus NS1 protein inhibits activation of Jun N-terminal kinase and AP-1 transcription factors.
###end article-title 96
###begin article-title 97
###xml 105 122 <span type="species:ncbi:11320">influenza A virus</span>
Inhibition of retinoic acid-inducible gene I-mediated induction of beta interferon by the NS1 protein of influenza A virus.
###end article-title 97
###begin article-title 98
###xml 21 38 <span type="species:ncbi:11320">influenza A virus</span>
IFNbeta induction by influenza A virus is mediated by RIG-I which is regulated by the viral NS1 protein.
###end article-title 98
###begin article-title 99
###xml 65 82 <span type="species:ncbi:11320">influenza A virus</span>
Activation of interferon regulatory factor 3 is inhibited by the influenza A virus NS1 protein.
###end article-title 99
###begin article-title 100
###xml 0 17 <span type="species:ncbi:11320">Influenza A virus</span>
Influenza A virus NS1 protein prevents activation of NF-kappaB and induction of alpha/beta interferon.
###end article-title 100
###begin article-title 101
Influenza virus NS1 protein enhances the rate of translation initiation of viral mRNAs.
###end article-title 101
###begin article-title 102
###xml 0 17 <span type="species:ncbi:11320">Influenza A virus</span>
Influenza A virus NS1 protein activates the PI3K/Akt pathway to mediate antiapoptotic signaling responses.
###end article-title 102
###begin article-title 103
Influenza virus NS1 protein inhibits pre-mRNA splicing and blocks mRNA nucleocytoplasmic transport.
###end article-title 103
###begin article-title 104
###xml 40 57 <span type="species:ncbi:11320">influenza A virus</span>
Multiple anti-interferon actions of the influenza A virus NS1 protein.
###end article-title 104
###begin article-title 105
The influenza virus NS1 protein: a novel inhibitor of pre-mRNA splicing.
###end article-title 105
###begin article-title 106
###xml 43 60 <span type="species:ncbi:11320">influenza A virus</span>
The primary function of RNA binding by the influenza A virus NS1 protein in infected cells: Inhibiting the 2'-5' oligo (A) synthetase/RNase L pathway.
###end article-title 106
###begin article-title 107
Translational control by influenza virus. Identification of cis-acting sequences and trans-acting factors which may regulate selective viral mRNA translation.
###end article-title 107
###begin article-title 108
The influenza virus NS1 protein is a poly(A)-binding protein that inhibits nuclear export of mRNAs containing poly(A).
###end article-title 108
###begin article-title 109
Influenza virus targets the mRNA export machinery and the nuclear pore complex.
###end article-title 109
###begin article-title 110
IFN-stimulated gene 15 functions as a critical antiviral molecule against influenza, herpes, and Sindbis viruses.
###end article-title 110
###begin article-title 111
###xml 0 17 <span type="species:ncbi:11520">Influenza B virus</span>
Influenza B virus NS1 protein inhibits conjugation of the interferon (IFN)-induced ubiquitin-like ISG15 protein.
###end article-title 111
###begin article-title 112
###xml 12 29 <span type="species:ncbi:11520">influenza B virus</span>
Analysis of influenza B virus NS1 protein trafficking reveals a novel interaction with nuclear speckle domains.
###end article-title 112
###begin article-title 113
###xml 23 27 <span type="species:ncbi:10090">mice</span>
Deficient signaling in mice devoid of double-stranded RNA-dependent protein kinase.
###end article-title 113
###begin article-title 114
###xml 0 17 <span type="species:ncbi:11520">Influenza B virus</span>
Influenza B virus NS1-truncated mutants: live-attenuated vaccine approach.
###end article-title 114
###begin article-title 115
Interaction of the influenza virus nucleoprotein with the cellular CRM1-mediated nuclear export pathway.
###end article-title 115
###begin article-title 116
###xml 22 39 <span type="species:ncbi:11320">influenza A virus</span>
Defective assembly of influenza A virus due to a mutation in the polymerase subunit PA.
###end article-title 116
###begin article-title 117
5'-triphosphate-dependent activation of PKR by RNAs with short stem-loops.
###end article-title 117
###begin article-title 118
Activation of the protein kinase PKR by short double-stranded RNAs with single-stranded tails.
###end article-title 118
###begin article-title 119
Genomic RNAs of influenza viruses are held in a circular conformation in virions and in infected cells by a terminal panhandle.
###end article-title 119
###begin article-title 120
Structural features of an influenza virus promoter and their implications for viral RNA synthesis.
###end article-title 120
###begin article-title 121
Roles of the influenza virus polymerase and nucleoprotein in forming a functional RNP structure.
###end article-title 121
###begin article-title 122
5'-Triphosphate RNA is the ligand for RIG-I.
###end article-title 122
###begin article-title 123
###xml 14 31 <span type="species:ncbi:11320">influenza A virus</span>
A site on the influenza A virus NS1 protein mediates both inhibition of PKR activation and temporal regulation of viral RNA synthesis.
###end article-title 123
###begin article-title 124
###xml 67 84 <span type="species:ncbi:11320">influenza A virus</span>
Biochemical and genetic evidence for complex formation between the influenza A virus NS1 protein and the interferon-induced PKR protein kinase.
###end article-title 124
###begin article-title 125
###xml 87 104 <span type="species:ncbi:11320">influenza A virus</span>
Amino acid replacements leading to temperature-sensitive defects of the NS1 protein of influenza A virus.
###end article-title 125
###begin article-title 126
Bunyaviridae: The viruses and their replication.
###end article-title 126
###begin article-title 127
###xml 21 37 <span type="species:ncbi:35304">Bunyamwera virus</span>
Activation of PKR by Bunyamwera virus is independent of the viral interferon antagonist NSs.
###end article-title 127
###begin article-title 128
###xml 20 31 <span type="species:ncbi:205488">Ebola virus</span>
The VP35 protein of Ebola virus inhibits the antiviral effect mediated by double-stranded RNA-dependent protein kinase PKR.
###end article-title 128
###begin article-title 129
###xml 4 10 <span type="species:ncbi:10090">murine</span>
###xml 90 116 <span type="species:ncbi:11276">vesicular stomatitis virus</span>
The murine double-stranded RNA-dependent protein kinase PKR is required for resistance to vesicular stomatitis virus.
###end article-title 129
###begin article-title 130
Novel influenza NS1 antagonists block replication and restore innate immune function.
###end article-title 130
###begin article-title 131
Promoter analysis of influenza virus RNA polymerase.
###end article-title 131
###begin p 132
The authors have declared that no competing interests exist.
###end p 132
###begin p 133
The work was supported by grants from the German Ministry of Health (FSI program) and the European Union (FluVacc; contract No. 518281) to T.W. as well as by grants from the NIH, R01 AI46954, U01 AI70469, U19 AI62623 (Center for Investigating Viral Immunity and Antagonism), and by CRIP (Center for Research on Influenza Pathogenesis, NIAID contract HHSN266200700010C) to A.G-S. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
###end p 133

